28.01.2020
CHEPLAPHARM announces pricing of Senior Secured Notes
Cheplapharm has priced €500 million aggregate principal amount of its 3.500% senior secured notes due 2027 (the “Notes”), at an offering price of 100.0%.
Investor Relations Archiv Weiterlesenchevron_right